Mercury Laboratories Limited (BOM:538964)
India
· Delayed Price · Currency is INR 849.05
-44.35 (-4.96%)
At close: May 8, 2025
Mercury Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Operating Revenue | 718.09 | 755.59 | 753.34 | 579.24 | 686.02 | 572.69 | Upgrade
|
| Revenue | 718.09 | 755.59 | 753.34 | 579.24 | 686.02 | 572.69 | Upgrade
|
| Revenue Growth (YoY) | -7.49% | 0.30% | 30.06% | -15.57% | 19.79% | 3.15% | Upgrade
|
| Cost of Revenue | 293.98 | 325.43 | 328.94 | 247.77 | 322.43 | 266.68 | Upgrade
|
| Gross Profit | 424.11 | 430.16 | 424.39 | 331.46 | 363.59 | 306.01 | Upgrade
|
| Selling, General & Admin | 157.9 | 145.01 | 142.45 | 124.97 | 98 | 93.01 | Upgrade
|
| Other Operating Expenses | 174.05 | 178.13 | 189 | 134.96 | 159.23 | 149.92 | Upgrade
|
| Operating Expenses | 375.03 | 365.75 | 361.11 | 284.6 | 286.89 | 263.04 | Upgrade
|
| Operating Income | 49.09 | 64.41 | 63.28 | 46.87 | 76.7 | 42.97 | Upgrade
|
| Interest Expense | -1.95 | -0.65 | -0.57 | -1.7 | -2.54 | -3.85 | Upgrade
|
| Interest & Investment Income | 1.2 | 1.2 | 1.24 | 0.88 | 0.58 | 0.69 | Upgrade
|
| Currency Exchange Gain (Loss) | 4.58 | 4.58 | 12.4 | 4.31 | 2.73 | 1.21 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.05 | -1.01 | -1.63 | -1.52 | 1.55 | 2.25 | Upgrade
|
| EBT Excluding Unusual Items | 53.97 | 68.53 | 74.71 | 48.84 | 79.02 | 43.27 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.68 | 0.68 | -0.27 | 0.23 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | 1.28 | - | - | Upgrade
|
| Pretax Income | 54.64 | 69.2 | 74.45 | 50.34 | 79.09 | 43.29 | Upgrade
|
| Income Tax Expense | 15.19 | 12.66 | 18.66 | 14.73 | 25.72 | 11.01 | Upgrade
|
| Net Income | 39.45 | 56.54 | 55.79 | 35.62 | 53.38 | 32.28 | Upgrade
|
| Net Income to Common | 39.45 | 56.54 | 55.79 | 35.62 | 53.38 | 32.28 | Upgrade
|
| Net Income Growth | -4.03% | 1.35% | 56.62% | -33.27% | 65.34% | 13.82% | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| EPS (Basic) | 32.88 | 47.12 | 46.49 | 29.68 | 44.48 | 26.90 | Upgrade
|
| EPS (Diluted) | 32.88 | 47.12 | 46.49 | 29.68 | 44.48 | 26.90 | Upgrade
|
| EPS Growth | -4.00% | 1.35% | 56.64% | -33.27% | 65.34% | 13.84% | Upgrade
|
| Free Cash Flow | - | 19.53 | 13.96 | 32.74 | 35.95 | 43.52 | Upgrade
|
| Free Cash Flow Per Share | - | 16.28 | 11.63 | 27.29 | 29.95 | 36.26 | Upgrade
|
| Dividend Per Share | - | 3.500 | 3.500 | 3.500 | 3.500 | 2.000 | Upgrade
|
| Dividend Growth | - | - | - | - | 75.00% | 33.33% | Upgrade
|
| Gross Margin | 59.06% | 56.93% | 56.34% | 57.22% | 53.00% | 53.43% | Upgrade
|
| Operating Margin | 6.84% | 8.52% | 8.40% | 8.09% | 11.18% | 7.50% | Upgrade
|
| Profit Margin | 5.49% | 7.48% | 7.41% | 6.15% | 7.78% | 5.64% | Upgrade
|
| Free Cash Flow Margin | - | 2.58% | 1.85% | 5.65% | 5.24% | 7.60% | Upgrade
|
| EBITDA | 70.48 | 85.58 | 84.14 | 67.39 | 95.74 | 61.24 | Upgrade
|
| EBITDA Margin | 9.81% | 11.33% | 11.17% | 11.63% | 13.96% | 10.69% | Upgrade
|
| D&A For EBITDA | 21.4 | 21.17 | 20.86 | 20.52 | 19.04 | 18.27 | Upgrade
|
| EBIT | 49.09 | 64.41 | 63.28 | 46.87 | 76.7 | 42.97 | Upgrade
|
| EBIT Margin | 6.84% | 8.52% | 8.40% | 8.09% | 11.18% | 7.50% | Upgrade
|
| Effective Tax Rate | 27.80% | 18.30% | 25.06% | 29.25% | 32.51% | 25.43% | Upgrade
|
| Revenue as Reported | 731.05 | 766.48 | 770.53 | 587.4 | 694.82 | 581.19 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.